Web13 apr. 2024 · A high-level overview of Infinity Pharmaceuticals, Inc. (INFI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Web1 dag geleden · Infinity Pharmaceuticals Announces Two Upcoming Presentations on PI3K-γ and Eganelisib by Dr. Judith Varner at the 2024 Annual Meeting of the American Association of Cancer Research ... This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.
Investor Summary MEI Pharma
WebChair and Chief Executive Officer. Adelene Perkins serves as Infinity’s chief executive officer and Infinity’s chair, a position she has held since 2012. She was named chief executive officer and elected to the Board of Directors in 2009. Before serving as CEO, Ms. Perkins served as Infinity’s President, a position she held since 2008. body swaying when standing
Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with …
Web12 feb. 2024 · Infinity Pharmaceuticals, Inc., ... This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Web31 dec. 2024 · Infinity Pharmaceuticals Reports Full Year 2024 Financial Results. – Infinity ended 2024 with total cash and cash equivalents of $38.3 million –. – Infinity Previously … Web5 jan. 2024 · Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer in multiple clinical … body swap writing